Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Carla M. Canuso, MD
JCP
Original Research
Esketamine Nasal Spray Rapidly Reduces Depression
May 12, 2020
There is an unmet need in patients with depression and active suicidal ideation for new therapies that can rapidly bridge the gap until antidepressants take effect. Read this article...
Dong-Jing Fu
,
Dawn F. Ionescu
,
Xiang Li
, et al
JCP
Original Research
Paliperidone Palmitate Once-Monthly Reduces Risk of Relapse of Psychotic, Depressive, and Manic Symptoms and Maintains Functioning in a Double-Blind, Randomized Study of Schizoaffective Disorder
December 5, 2014
Dong-Jing Fu
,
Ibrahim Turkoz
,
R. Bruce Simonson
, et al
JCP
Original Research
A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder
May 15, 2010
Carla M. Canuso
,
Jean-Pierre Lindenmayer
,
Colette Kosik-Gonzalez
, et al
JCP
Letter to the Editor
Methodological Issues in a Comparative Study of Ziprasidone and Risperidone
January 16, 2006
Georges M. Gharabawi
,
Cynthia A. Bossie
,
Ramy Mahmoud
, et al
